1. Home
  2. CBAT vs VERU Comparison

CBAT vs VERU Comparison

Compare CBAT & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBAT
  • VERU
  • Stock Information
  • Founded
  • CBAT 1999
  • VERU 1971
  • Country
  • CBAT China
  • VERU United States
  • Employees
  • CBAT 1463
  • VERU N/A
  • Industry
  • CBAT Industrial Machinery/Components
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBAT Miscellaneous
  • VERU Health Care
  • Exchange
  • CBAT Nasdaq
  • VERU Nasdaq
  • Market Cap
  • CBAT 102.5M
  • VERU 94.5M
  • IPO Year
  • CBAT N/A
  • VERU 1990
  • Fundamental
  • Price
  • CBAT $1.16
  • VERU $0.62
  • Analyst Decision
  • CBAT
  • VERU Strong Buy
  • Analyst Count
  • CBAT 0
  • VERU 2
  • Target Price
  • CBAT N/A
  • VERU $4.00
  • AVG Volume (30 Days)
  • CBAT 310.3K
  • VERU 3.1M
  • Earning Date
  • CBAT 08-08-2025
  • VERU 08-07-2025
  • Dividend Yield
  • CBAT N/A
  • VERU N/A
  • EPS Growth
  • CBAT N/A
  • VERU N/A
  • EPS
  • CBAT 0.00
  • VERU N/A
  • Revenue
  • CBAT $152,731,078.00
  • VERU $16,886,419.00
  • Revenue This Year
  • CBAT $28.79
  • VERU N/A
  • Revenue Next Year
  • CBAT $36.77
  • VERU N/A
  • P/E Ratio
  • CBAT $12,978.44
  • VERU N/A
  • Revenue Growth
  • CBAT N/A
  • VERU 134.43
  • 52 Week Low
  • CBAT $0.57
  • VERU $0.45
  • 52 Week High
  • CBAT $1.45
  • VERU $1.42
  • Technical
  • Relative Strength Index (RSI)
  • CBAT 64.33
  • VERU 58.35
  • Support Level
  • CBAT $1.07
  • VERU $0.56
  • Resistance Level
  • CBAT $1.23
  • VERU $0.65
  • Average True Range (ATR)
  • CBAT 0.06
  • VERU 0.05
  • MACD
  • CBAT -0.00
  • VERU 0.00
  • Stochastic Oscillator
  • CBAT 71.43
  • VERU 52.94

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: